Gregory J. Carven

Person

Maynard, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Tissue factor pathway inhibitor antibodies and uses thereof
- Patent number 12,168,698
- Issue date Dec 17, 2024
- Pfizer Inc.
- Debra Pittman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Isoform-selective TGFB1 inhibitors and use thereof
- Patent number 12,122,823
- Issue date Oct 22, 2024
- SCHOLAR ROCK, INC.
- Abhishek Datta
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGFβ1-binding immunoglobulins and use thereof
- Patent number 11,643,459
- Issue date May 9, 2023
- SCHOLAR ROCK, INC.
- Thomas Schurpf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tissue factor pathway inhibitor antibodies and uses thereof
- Patent number 11,634,504
- Issue date Apr 25, 2023
- Pfizer Inc.
- Debra Pittman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for using anti-myostatin antibodies
- Patent number 11,439,704
- Issue date Sep 13, 2022
- SCHOLAR ROCK, INC.
- Gregory J. Carven
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoform-selective TGFβ1 inhibitors and use thereof
- Patent number 11,130,803
- Issue date Sep 28, 2021
- SCHOLAR ROCK, INC.
- Abhishek Datta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to human programmed death receptor PD-1
- Patent number 11,117,961
- Issue date Sep 14, 2021
- Merck Sharp & Dohme B.V.
- Gregory John Carven
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tissue factor pathway inhibitor antibodies and uses thereof
- Patent number 10,875,929
- Issue date Dec 29, 2020
- Pfizer Inc.
- Debra Pittman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-pro/latent-Myostatin antibodies and uses thereof
- Patent number 10,751,413
- Issue date Aug 25, 2020
- SCHOLAR ROCK, INC.
- Gregory J. Carven
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tissue factor pathway inhibitor antibodies and uses thereof
- Patent number 10,550,200
- Issue date Feb 4, 2020
- Pfizer Inc.
- Debra Pittman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies to human programmed death receptor PD-1
- Patent number 9,834,605
- Issue date Dec 5, 2017
- Merck Sharpe & Dohme B.V.
- Gregory John Carven
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Platelet-derived growth factor B specific antibodies and compositio...
- Patent number 9,428,577
- Issue date Aug 30, 2016
- Pfizer Inc.
- Robert Arch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies to human programmed death receptor PD-1
- Patent number 8,952,136
- Issue date Feb 10, 2015
- Merck Sharp & Dohme B.V.
- Gregory John Carven
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies to human programmed death receptor PD-1
- Patent number 8,900,587
- Issue date Dec 2, 2014
- Merck Sharp & Dohme Corp.
- Gregory John Carven
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies to human programmed death receptor PD-1
- Patent number 8,354,509
- Issue date Jan 15, 2013
- Msd Oss B.V
- Gregory John Carven
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
- Publication number 20240016928
- Publication date Jan 18, 2024
- Scholar Rock, Inc.
- Thomas Schurpf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF
- Publication number 20230416405
- Publication date Dec 28, 2023
- Pfizer Inc.
- Debra Pittman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGFbeta1-BINDING IMMUNOGLOBULINS AND USE THEREOF
- Publication number 20230348583
- Publication date Nov 2, 2023
- Scholar Rock, Inc.
- Thomas Schurpf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF
- Publication number 20230190929
- Publication date Jun 22, 2023
- Scholar Rock, Inc.
- Gregory J. Carven
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF
- Publication number 20220064275
- Publication date Mar 3, 2022
- Scholar Rock, Inc.
- Abhishek Datta
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
- Publication number 20210403560
- Publication date Dec 30, 2021
- Merck Sharp & Dohme B.V.
- Gregory John Carven
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGFß1 INHIBITORS AND USE THEREOF
- Publication number 20210340238
- Publication date Nov 4, 2021
- Scholar Rock, Inc.
- Abhishek Datta
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGFBeta Antibodies, Methods and Uses
- Publication number 20210277100
- Publication date Sep 9, 2021
- Scholar Rock, Inc.
- Gregory J. Carven
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOF
- Publication number 20210122814
- Publication date Apr 29, 2021
- Scholar Rock, Inc.
- Abhishek Datta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF
- Publication number 20210101998
- Publication date Apr 8, 2021
- Pfizer Inc.
- Debra Pittman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF
- Publication number 20210046180
- Publication date Feb 18, 2021
- Scholar Rock, Inc.
- Gregory J. Carven
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LTBP COMPLEX-SPECIFIC INHIBITORS OF TGF-BETA 1 AND USES THEREOF
- Publication number 20200231682
- Publication date Jul 23, 2020
- Scholar Rock, Inc.
- Thomas Schurpf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF
- Publication number 20200190214
- Publication date Jun 18, 2020
- Pfizer Inc.
- Debra Pittman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LRRC33 INHIBITORS AND USE THEREOF
- Publication number 20200181251
- Publication date Jun 11, 2020
- Scholar Rock, Inc.
- Alan Buckler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF
- Publication number 20200079840
- Publication date Mar 12, 2020
- Scholar Rock, Inc.
- Abhishek Datta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGFBeta Antibodies, Methods and Uses
- Publication number 20190292254
- Publication date Sep 26, 2019
- Scholar Rock, Inc.
- Gregory J. Carven
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
- Publication number 20190209682
- Publication date Jul 11, 2019
- Scholar Rock, Inc.
- Thomas Schurpf
- G01 - MEASURING TESTING
Information Patent Application
TGFbeta1-BINDING IMMUNOGLOBULINS AND USE THEREOF
- Publication number 20190071493
- Publication date Mar 7, 2019
- Scholar Rock, Inc.
- Thomas Schurpf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF
- Publication number 20180344844
- Publication date Dec 6, 2018
- Scholar Rock, Inc.
- Gregory J. Carven
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
- Publication number 20180207267
- Publication date Jul 26, 2018
- Scholar Rock, Inc.
- Thomas Schurpf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
- Publication number 20180111996
- Publication date Apr 26, 2018
- Merck Sharp & Dohme B.V.
- Gregory John Carven
- G01 - MEASURING TESTING
Information Patent Application
ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF
- Publication number 20170333558
- Publication date Nov 23, 2017
- Scholar Rock, Inc.
- Michelle Straub
- G01 - MEASURING TESTING
Information Patent Application
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF
- Publication number 20170073428
- Publication date Mar 16, 2017
- Pfizer Inc.
- Debra Pittman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
- Publication number 20160304606
- Publication date Oct 20, 2016
- Merck Sharp & Dohme B.V.
- Gregory John Carven
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
- Publication number 20150232555
- Publication date Aug 20, 2015
- Merck Sharp & Dohme B.V.
- Gregory John Carven
- G01 - MEASURING TESTING
Information Patent Application
PLATELET-DERIVED GROWTH FACTOR B SPECIFIC ANTIBODIES AND COMPOSITIO...
- Publication number 20140134176
- Publication date May 15, 2014
- Pfizer Inc.
- Robert ARCH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
- Publication number 20130109843
- Publication date May 2, 2013
- MDS OSS B.V.
- Gregory John Carven
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
- Publication number 20130108651
- Publication date May 2, 2013
- MSD OSS B.V.
- Gregory John Carven
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
- Publication number 20100266617
- Publication date Oct 21, 2010
- N.V. Organon
- Gregory John Carven
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Major histocompatibility complex (MHC)-peptide arrays
- Publication number 20040248205
- Publication date Dec 9, 2004
- Lawrence J. Stern
- G01 - MEASURING TESTING

Gregory J. Carven

Person

Patents Grantslast 30 patents

Tissue factor pathway inhibitor antibodies and uses thereof

Isoform-selective TGFB1 inhibitors and use thereof

TGFβ1-binding immunoglobulins and use thereof

Tissue factor pathway inhibitor antibodies and uses thereof

Methods for using anti-myostatin antibodies

Isoform-selective TGFβ1 inhibitors and use thereof

Antibodies to human programmed death receptor PD-1

Tissue factor pathway inhibitor antibodies and uses thereof

Anti-pro/latent-Myostatin antibodies and uses thereof

Tissue factor pathway inhibitor antibodies and uses thereof

Antibodies to human programmed death receptor PD-1

Platelet-derived growth factor B specific antibodies and compositio...

Antibodies to human programmed death receptor PD-1

Antibodies to human programmed death receptor PD-1

Antibodies to human programmed death receptor PD-1

Patents Applicationslast 30 patents

ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF

TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF

TGFbeta1-BINDING IMMUNOGLOBULINS AND USE THEREOF

ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF

ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF

ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1

TGFß1 INHIBITORS AND USE THEREOF

TGFBeta Antibodies, Methods and Uses

HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOF

TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF

ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF

LTBP COMPLEX-SPECIFIC INHIBITORS OF TGF-BETA 1 AND USES THEREOF

TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF

LRRC33 INHIBITORS AND USE THEREOF

ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF

TGFBeta Antibodies, Methods and Uses

ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF

TGFbeta1-BINDING IMMUNOGLOBULINS AND USE THEREOF

ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF

ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF

ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1

ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF

TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF

ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1

ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1

PLATELET-DERIVED GROWTH FACTOR B SPECIFIC ANTIBODIES AND COMPOSITIO...

ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1

ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1

ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1

Major histocompatibility complex (MHC)-peptide arrays